Specific targets are the receptors for vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and epidermal growth factor (EGF), which are all involved in (tumor) angiogenesis (3, 6). This evidence concerns the gene VEGFA and neoplasm.